Here is the latest stock price and chart of SAMRAT PHARMA. For more details, see the SAMRAT PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Revealing Soon: A Potential Huge Investing Opportunity for Investors
Live BSE Quotes | May 23, 2024 (Close) | ||
---|---|---|---|
Price (Rs)371.95 | Open (Rs) 374.45 | High (Rs) 374.45 | Low (Rs) 361.50 |
% Change2.81 | Volume 710 | Value (Rs) 262,480 | 52-Week H/L 533.60 / 320.00 |
Live NSE Quotes |
---|
Not listed |
Change | |||||
---|---|---|---|---|---|
1 Day 2.81% | 1 Month -0.83% | 3 Months -3.63% | 1 Year -26.11% | 5 Years (CAGR)* 33.01% | 10 Years (CAGR)* 30.43% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 0.07 | P/E Ratio (x) 5,223.70 | Market Cap (Rs m) 1,149.21 | P/BV (x) 1.76 | Dividend Yield (%) 0.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
|
||
S&P BSE SENSEX
|
||||||
PERIOD |
SAMRAT PHARMA last traded price was up 2.8% to Rs 372.0 on the BSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.6%. And the benchmark S&P BSE SENSEX was at 75,418.0 (up 1.6%).
Over the last 30 days, the SAMRAT PHARMA share price is down 0.6%. And over the last one year, SAMRAT PHARMA share price is down 27.0%.
The current market capitalisation of SAMRAT PHARMA stands at Rs 1,149.21 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2024, company promoters held 48.64% stake in SAMRAT PHARMA, with no shares having been pledged. To know more, check out the latest shareholding pattern of SAMRAT PHARMA.
Before you go, here's an alert on SAMRAT PHARMA you may want to take note of...
Date | Announcement | Ex-Date |
---|---|---|
30-May-2024 | Quarterly Results | - |
List of All Upcoming Corporate Actions
The last traded price of SAMRAT PHARMA was Rs 372.0 on the BSE, up 2.8% over the previous close.
The current market capitalisation of SAMRAT PHARMA stands at Rs 1,149 m.
SAMRAT PHARMA had an EPS of Rs 0.1 in the latest financial year.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.